•
Nov 21, 2024
Nov 18, 2024
Nov 17, 2024
Nov 12, 2024
Nov 20, 2024
Nov 8, 2024
Nov 7, 2024
Nov 6, 2024
Gain Therapeutics, Inc. [GANX] has reported fiscal Q1 loss of $5.10 million.
On a per-share basis, the DE based company said its diluted earnings are $0.43.
The Pharmaceutical Preparations firm posted revenue of $55.20 million in this period.